11th Annual: Latest Advancements and Data in Immuno-Oncology

11th Annual: Latest Advancements and Data in Immuno-Oncology is organized by The Conference Forum (TCF) and will be held from Mar 24 - 26, 2025 at Sheraton Boston Hotel, Boston, Massachusetts, United States of America.

Description:
Hear directly from science and business stakeholders on the latest data impacting IO to fight a wider range of cancers.

IO360° Delivers 4 Key Benefits:

• Delivering a 360° IO Community? to Network and Form Collaborations Build faster and more impactful collaborations with researchers, clinicians, biopharma leaders, investors and policymakers to advance cancer treatments
• The Latest Data Driving Broader Impact Hear directly from KOLs on the latest data to help advance and improve outcomes for more patients across a wider range of cancers
• 360° Future-Focused Agenda Stay ahead of the curve through 100+ multi-dimensional talks covering preclinical research, translational science, clinical development, operational strategies, cell therapy and business advancements
• 10+ Hours of Networking Opportunities Meet with key stakeholders in biopharma, academia, investors and regulatory through 1:1 meetings and scheduled functions

2025 Key Topics:

• Biomarkers/Assay Development 
• Business and Investing Aspects
• Discovery/Preclinical
• Autoimmune Disease & IO
• ADCs & IO
• IO Combinations
• Translational Science
• Imaging Advancements
• Cell Therapy
• Clinical Operations
• Clinical Developments
• Neoadjuvant/Adjuvant Therapy
• New Tech in Transformational Biology
• And More